Zhejiang Qianjiang Biochemical Co., Ltd (SHA:600796)
6.94
-0.35 (-4.80%)
Feb 6, 2026, 3:00 PM CST
SHA:600796 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,663 | 1,765 | 2,031 | 2,004 | 2,020 | 1,879 |
Other Revenue | 3.58 | 3.58 | 3.74 | 4.46 | 11.06 | 9.12 |
| 1,666 | 1,768 | 2,034 | 2,009 | 2,031 | 1,888 | |
Revenue Growth (YoY) | -16.95% | -13.08% | 1.27% | -1.08% | 7.55% | 396.55% |
Cost of Revenue | 1,250 | 1,364 | 1,556 | 1,569 | 1,564 | 1,480 |
Gross Profit | 416.29 | 404.83 | 478.75 | 439.57 | 466.59 | 408.36 |
Selling, General & Admin | 155.18 | 159.79 | 166.45 | 150.15 | 136.98 | 133.19 |
Research & Development | 32.05 | 29.83 | 28.41 | 31.45 | 32.03 | 18.62 |
Other Operating Expenses | 12.67 | 3.76 | -0.49 | 6.83 | 3.17 | 0.69 |
Operating Expenses | 231.76 | 236.11 | 213.37 | 190.37 | 175.12 | 172.84 |
Operating Income | 184.52 | 168.72 | 265.38 | 249.2 | 291.48 | 235.53 |
Interest Expense | -70.61 | -78.71 | -89.12 | -92.43 | -75.36 | -75.97 |
Interest & Investment Income | 89.71 | 75.36 | 60.54 | 70.34 | 5.32 | 9.56 |
Currency Exchange Gain (Loss) | 1.05 | 1.05 | 0.66 | 1.72 | 1.7 | -2.72 |
Other Non Operating Income (Expenses) | -3.75 | -7.4 | -10.2 | -15.19 | -18.54 | -10.45 |
EBT Excluding Unusual Items | 200.91 | 159.02 | 227.26 | 213.63 | 204.6 | 155.94 |
Gain (Loss) on Sale of Assets | 1.7 | 0.89 | 9.1 | 9.52 | 0.51 | -0.45 |
Asset Writedown | 1.3 | 1.34 | -9.26 | -3.01 | - | -8.21 |
Other Unusual Items | 13.09 | 13.09 | 1.73 | 20.12 | 4.62 | 27.57 |
Pretax Income | 216.99 | 174.33 | 228.84 | 240.27 | 209.73 | 174.86 |
Income Tax Expense | 54.4 | 48.98 | 45.94 | 50.17 | 46.98 | 51.87 |
Earnings From Continuing Operations | 162.59 | 125.35 | 182.9 | 190.1 | 162.75 | 122.98 |
Minority Interest in Earnings | 19.94 | 34.65 | 27.79 | 15.95 | -14.81 | -26.85 |
Net Income | 182.54 | 160 | 210.69 | 206.05 | 147.94 | 96.14 |
Net Income to Common | 182.54 | 160 | 210.69 | 206.05 | 147.94 | 96.14 |
Net Income Growth | -8.71% | -24.06% | 2.25% | 39.28% | 53.89% | 401.22% |
Shares Outstanding (Basic) | 913 | 889 | 878 | 859 | 672 | 641 |
Shares Outstanding (Diluted) | 913 | 889 | 878 | 859 | 672 | 641 |
Shares Change (YoY) | 5.16% | 1.26% | 2.25% | 27.67% | 4.92% | 100.49% |
EPS (Basic) | 0.20 | 0.18 | 0.24 | 0.24 | 0.22 | 0.15 |
EPS (Diluted) | 0.20 | 0.18 | 0.24 | 0.24 | 0.22 | 0.15 |
EPS Growth | -13.18% | -25.00% | - | 9.09% | 46.67% | 150.00% |
Free Cash Flow | 84.43 | -446.07 | 117.73 | 34.38 | -199.62 | 47.29 |
Free Cash Flow Per Share | 0.09 | -0.50 | 0.13 | 0.04 | -0.30 | 0.07 |
Dividend Per Share | 0.031 | 0.031 | 0.031 | 0.102 | 0.100 | - |
Dividend Growth | - | - | -69.61% | 2.00% | - | - |
Gross Margin | 24.98% | 22.89% | 23.53% | 21.88% | 22.98% | 21.63% |
Operating Margin | 11.07% | 9.54% | 13.05% | 12.40% | 14.35% | 12.47% |
Profit Margin | 10.95% | 9.05% | 10.36% | 10.26% | 7.28% | 5.09% |
Free Cash Flow Margin | 5.07% | -25.22% | 5.79% | 1.71% | -9.83% | 2.50% |
EBITDA | 423.87 | 402.05 | 490.69 | 484.82 | 473.82 | 401.77 |
EBITDA Margin | 25.44% | 22.74% | 24.12% | 24.13% | 23.33% | 21.28% |
D&A For EBITDA | 239.35 | 233.33 | 225.31 | 235.62 | 182.35 | 166.24 |
EBIT | 184.52 | 168.72 | 265.38 | 249.2 | 291.48 | 235.53 |
EBIT Margin | 11.07% | 9.54% | 13.05% | 12.40% | 14.35% | 12.47% |
Effective Tax Rate | 25.07% | 28.09% | 20.08% | 20.88% | 22.40% | 29.67% |
Revenue as Reported | 1,666 | 1,768 | 2,034 | 2,009 | 2,031 | 1,888 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.